Biocompatible polymeric compositions for use in making posterior chamber intraocular lenses

A biocompatible polymer comprising:

• approximately 52 mass percent to approximately 56 mass percent of phenoxyethyl acrylate;
• approximately 18 mass percent to approximately 22 mass percent of ethyl acrylate;
• approximately 24 mass percent to approximately 28 mass percent of ethyl methacrylate;
• and
• approximately 3 mass percent to approximately 5 mass percent of ethylene glycol dimethacrylate;
• wherein said biocompatible polymer is used to form a posterior chamber intraocular lens.

A posterior chamber intraocular lens comprising:

• approximately 54 mass percent of phenoxyethyl acrylate;
• approximately 20 mass percent of ethyl acrylate;
• approximately 26 mass percent of ethyl methacrylate;
• and
• approximately 4 mass percent of glycol dimethacrylate;
• wherein residual solvents and UV absorbing compounds make up the remaining mass percentage such the total mass percent is 100.

A posterior chamber intraocular lens consisting essentially of:

• approximately 54 mass percent of phenoxyethyl acrylate;
• approximately 20 mass percent of ethyl acrylate;
• approximately 26 mass percent of ethyl methacrylate;
• and
• approximately 4 mass percent of glycol dimethacrylate;
• wherein residual solvents and UV absorbing compounds make up the remaining mass percentage such the total mass percent is 100.

A biocompatible polymer consisting essentially of:

• approximately 54 mass percent of phenoxyethyl acrylate;
• approximately 20 mass percent of ethyl acrylate;
• approximately 26 mass percent of ethyl methacrylate;
• and
• approximately 4 mass percent of glycol dimethacrylate;
• wherein residual solvents and UV absorbing compounds make up the remaining mass percentage such the total mass percent is 100 mass percent;
• and
• wherein said biocompatible polymer is used to form a posterior chamber intraocular lens.